Brief: Gain Therapeutics Appoints C. Evan Ballantyne As Chief Financial Officer
April 12 (Reuters) - Agenus Inc AGEN.O :
* GAIN THERAPEUTICS APPOINTS C. EVAN BALLANTYNE AS CHIEF
FINANCIAL
OFFICER
* GAIN THERAPEUTICS INC - BALLANTYNE SUCCEEDS SALVATORE
CALABRESE,
EXPECTED TO REMAIN EMPLOYED FOR A REASONABLE TRANSITION PERIOD
Source text for Eikon: ID:nGNX4N30RX
Further company coverage: AGEN.O
((Reuters.Brief@thomsonreuters.com;))
Recent news on Agenus
See all newsBrief: Agenus Reports 72% Of Patients With Locally Advanced Dmmr Colon Cancer Had No Cancer Remaining At Surgery Following Six Weeks Of Bot+Bal In Phase 2 Neoasis Study At Esmo 2026
Brief: Armenia Grants First Marketing Authorizations For Agenus’ Bot+Bal In Previously Treated Mss Metastatic Colorectal Cancer
Brief: Agenus - Unit Enters Second Loan Modification Agreement With Ocean 1181 On Aug 12, 2026 - SEC Filing
Agenus Inc reports results for the quarter ended June 30 - Earnings Summary
Agenus Q2 revenue rises on access and royalty income